INTERCEPT PHARMACEUTICALS, INC. Intellectual Property Contracts & Agreements
10 Contracts & Agreements
- License Agreements (9 contracts)
- Trademark Agreements (1)
- Master Trademark Assignment Agreement, dated May 5, 2022, by and among ICPT Inc., RXF Technologies, Inc. and Mercury Pharma (Filed With SEC on August 3, 2022)
- Amendment No. 3, dated as of February 13, 2018, to that certain License Agreement, dated March 29, 2011, between the Registrant and Sumitomo Dainippon Pharma Co., Ltd (Filed With SEC on May 10, 2018)
- Amendment No. 2, dated as of September 16, 2011, to that certain License Agreement, dated March 29, 2011, between the Registrant and Sumitomo Dainippon Pharma Co., Ltd (Filed With SEC on May 10, 2018)
- Amendment No. 1, dated as of June 8, 2011, to that certain License Agreement, dated March 29, 2011, between the Registrant and Sumitomo Dainippon Pharma Co., Ltd (Filed With SEC on May 10, 2018)
- AMENDMENT N°2 TO PRODUCT RESEARCH, DEVELOPMENT, LICENSE AND COMMERCIALIZATION AGREEMENT (this “Amendment”) (Filed With SEC on February 22, 2013)
- PRODUCT RESEARCH, DEVELOPMENT, LICENSE AND COMMERCIALIZATION AGREEMENT by and between LES LABORATOIRES SERVIER and INSTITUT DE RECHERCHES SERVIER on the one hand AND INTERCEPT... (Filed With SEC on September 27, 2012)
- LICENSE AGREEMENT (Filed With SEC on September 27, 2012)
- AMENDMENT N°1 TO PRODUCT RESEARCH, DEVELOPMENT, LICENSE AND COMMERCIALIZATION AGREEMENT (Filed With SEC on September 4, 2012)
- PRODUCT RESEARCH, DEVELOPMENT, LICENSE AND COMMERCIALIZATION AGREEMENT by and between LES LABORATOIRES SERVIER and INSTITUT DE RECHERCHES SERVIER on the one hand AND INTERCEPT... (Filed With SEC on September 4, 2012)
- LICENSE AGREEMENT (Filed With SEC on September 4, 2012)
